4 Analysts Have This to Say About Evolent Health
Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter:
Evolent Health Q1 EPS $0.12 Up From $(0.01) YoY, Sales $297.10M Beat $286.77M Estimate
Evolent Health (NYSE:EVH) reported quarterly earnings of $0.12 per share. This is a 1300 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $297.10
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Guggenheim Initiates Coverage On Evolent Health with Buy Rating, Announces Price Target of $43
Guggenheim analyst Sandy Draper initiates coverage on Evolent Health (NYSE:EVH) with a Buy rating and announces Price Target of $43.
10 Biggest Price Target Changes For Friday
Jefferies cut the price target on MEI Pharma, Inc. (NASDAQ: MEIP) from $4 to $1. MEI Pharma shares fell 44.2% to $1.01 in pre-market trading.
BTIG Maintains Buy on Evolent Health, Raises Price Target to $40
BTIG analyst David Larsen maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $35 to $40.
Evolent Health ‘Notification Award’ Removes $82M Overhang, Notes Piper Sandler
In an SEC filing, Cook County named Evolent Health Inc (NYSE:EVH) the sole third-party administrator for CountyCare Health Plan from…
44 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday.